Delivery Order SPE2DB22D2206-SPE2DB25FJP00
Award Date 8/21/25
Potential Completion Date 9/12/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp was awarded a competitively bid delivery order valued at $23,631.26 for BOSULIF 400 mg tablets (30-count packages) by the Defense Logistics Agency Medical Supply Chain on August 20, 2025, with an ultimate completion date of September 11, 2025. The contract employs firm fixed-price pricing with no set-aside designation, and performance will be executed from the contractor's Conshohocken, Pennsylvania location. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Bosulif 400 mg tablets (30-count units) under a firm fixed price contract with a ceiling value of $11,815.63 and completion deadline of August 29, 2025. This is a non-set-aside, competitively awarded delivery order that represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen Drug Corp, a major...
- This delivery order, awarded July 28, 2025, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides 120 tablets of Bosulif 100 mg with a ceiling value of $5,704.45 and a firm fixed price structure. The order is scheduled for completion by August 18, 2025, and will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award represents a non-competitive delivery order issued under a larger indefinite delivery contract vehicle that...
- This is a $5,704.45 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BOSULIF 100 MG TABLET 120S, a prescription medication, with a period of performance through July 23, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,815.63 contract is for the delivery of Bosulif 400 mg tablets, a prescription medication. The award has a performance period ending on June 30, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) valued at $999,999,999.00 with DLA Troop Support Medical, which allows the...
- The U.S. Defense Department's Medical Supply Chain issued a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Bosulif 400 mg tablets in a quantity of 30 units, with a firm fixed price ceiling value of $11,815.63 and ultimate completion date of August 29, 2025. This is a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,523.71 firm fixed-price delivery order is for the provision of 120 tablets of the medication BOSULIF 100 MG. The contract has an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for BOSULIF 400 mg tablets (30-count) with a ceiling value of $11,815.63. The contract, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, represents a firm fixed-price delivery order under a non-set-aside competitive procurement. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a delivery order valued at $5.7K to AmerisourceBergen Drug Corp for 120 tablets of Bosulif 100 mg, a tyrosine kinase inhibitor used in oncology treatment. The contract was competitively awarded without set-aside provisions under firm fixed pricing terms, with performance at the vendor's Conshohocken, Pennsylvania location and an ultimate completion date of August 15, 2025. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $11,239.34 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4562447812 Bosulif 400 MG tablets. The contract has no set-aside designation and requires delivery of 30 tablets to Conshohocken, Pennsylvania by November 1, 2023. As the Defense Logistics Agency is responsible for procuring pharmaceuticals and medical supplies for the U.S. military and other government agencies,...